Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
about
Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: Three major threats to hematopoietic stem cell transplant recipients.Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.Emergence of linezolid- and vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation.Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis.Significant Publications on Infectious Diseases Pharmacotherapy in 2016.Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-resistant Enterococcus faecium Isolates in an In Vitro PK/PD Model of Infection.Treatment of Vancomycin-Resistant Enterococci: Focus on Daptomycin.Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes.Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure.Genome-based analysis of Enterococcus faecium bacteremia associated with recurrent and mixed strain infection.Daptomycin.In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention.Institution-wide and Within-Patient Evolution of Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium Bloodstream Infections.Multiple-Dose Oritavancin Evaluation in a Retrospective Cohort of Patients with Complicated Infections.Risk Factors and Outcomes Associated With Acquisition of Daptomycin and Linezolid-Nonsusceptible Vancomycin-Resistant Enterococcus
P2860
Q38620812-52C5E4AB-C395-4055-94FB-08A94BEF9536Q38738512-B1002D11-C203-4D95-AFCF-8C17822BD648Q38968737-85C91B2F-1DF4-4EA7-A8C2-744FBC0A7679Q39168565-D1C476B6-BC03-4675-BF50-88B9D3E99080Q39202357-D10095E4-9E0F-4107-997F-E7FA2C17FA18Q40067736-098E05F8-5AEF-460C-9EBE-C299ACCE86E3Q40103272-EB3A3735-BDC6-49AC-80D7-627411AF9574Q40105754-7C441427-B40E-461C-8ED5-6AE4F2D47C34Q40254524-F76BFBF0-1FD8-42A0-99C4-F5B30B638877Q40280282-3ED5D394-4203-4147-89D0-C9535E3D484AQ40306161-2C27FA29-282B-42C5-A54D-EB3CA90E4588Q40451844-AC1324EE-C1E4-4120-A93E-FDD189A67E8FQ47188356-80041DE8-F912-4AA9-B3A4-11D40467DEFCQ47616115-4DEBFC77-E37E-4F48-B0CA-EA84299F3EDAQ48539876-35DAE065-6B98-4743-A2C1-E005DFE3F22CQ49176485-597A76D7-ED10-442B-90F4-5A80243B47BDQ49446863-9EDE6D31-A5AE-46D6-99E8-09FC4F63ECCBQ50056458-0E553837-EAF5-4989-9876-2944D6A8101DQ50091622-2677859B-F1B1-43AF-BD2A-7F00F58CC9D1Q57480754-9616C01B-7527-4FE3-9189-CB7304307EBF
P2860
Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Influence of Minimum Inhibitor ...... Time to Change the Breakpoint?
@ast
Influence of Minimum Inhibitor ...... Time to Change the Breakpoint?
@en
type
label
Influence of Minimum Inhibitor ...... Time to Change the Breakpoint?
@ast
Influence of Minimum Inhibitor ...... Time to Change the Breakpoint?
@en
prefLabel
Influence of Minimum Inhibitor ...... Time to Change the Breakpoint?
@ast
Influence of Minimum Inhibitor ...... Time to Change the Breakpoint?
@en
P2093
P2860
P356
P1476
Influence of Minimum Inhibitor ...... Time to Change the Breakpoint?
@en
P2093
Bhavarth S Shukla
Cesar A Arias
Diana Panesso
Eric G Pamer
Javier Adachi
Jessica D Lewis
Jinnethe Reyes
Jose M Munita
Katherine Reyes
Lina P Carvajal
P2860
P304
P356
10.1093/CID/CIW173
P407
P577
2016-04-03T00:00:00Z